Researchers found that Banner Health has successfully performed over 50 implants of the SynCardia Total Artificial Heart (STAH), making it one of the leading centers for this life-saving technology. The STAH is designed for patients with end-stage heart failure who are waiting for a heart transplant. This innovative device replaces both ventricles and all four heart valves, helping to restore circulation and stability while patients await donor hearts.

This development is significant for anyone concerned about heart health, especially those with advanced heart failure. With more than 6 million adults in the U.S. living with heart failure, the STAH offers hope by providing a bridge to transplant for patients who might otherwise have limited options. The experience gained from these implants contributes to improving surgical techniques and patient management, potentially leading to better outcomes for those facing severe heart issues.

The findings come from clinical practice at Banner Health, which has established a robust program in total artificial heart therapy. With over 2,100 STAH implants performed worldwide, the evidence shows that this therapy is gaining traction and acceptance in the medical community. While the results are promising, they are based on clinical experience rather than large-scale trials specifically designed to measure long-term outcomes.

For those interested in heart health, staying informed about advancements like the STAH can be beneficial. If you or someone you know is at risk for heart failure, consider discussing the latest treatment options with a healthcare provider. Understanding available therapies can empower you to make informed decisions about heart health and longevity.

Source: globenewswire.com